SPONSOR
Vanderbilt-Ingram Cancer Center
Total Trials
4
Recruiting
4
Phases
EARLY_Phase 1, Phase 1, Phase 2
Conditions studied: Stage I Lung CancerStage II Lung CancerLocally Advanced CancerMetastatic CancerHER2HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell CarcinomaHER 2 Low-expressing Breast CancerLung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage III Lung Cancer
Vanderbilt-Ingram Cancer Center is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Stage I Lung Cancer, Stage II Lung Cancer, Locally Advanced Cancer, Metastatic Cancer.
The trial portfolio spans EARLY_Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Vanderbilt-Ingram Cancer Center
How many clinical trials has Vanderbilt-Ingram Cancer Center sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Vanderbilt-Ingram Cancer Center, of which 4 are actively recruiting participants. These trials cover conditions including Stage I Lung Cancer, Stage II Lung Cancer, Locally Advanced Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Vanderbilt-Ingram Cancer Center research focus on?
Vanderbilt-Ingram Cancer Center clinical trials span Stage I Lung Cancer, Stage II Lung Cancer, Locally Advanced Cancer, Metastatic Cancer, HER2, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Vanderbilt-Ingram Cancer Center clinical trial?
To participate in a Vanderbilt-Ingram Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Vanderbilt-Ingram Cancer Center trials with current recruitment status updated daily.
Clinical Trials by Vanderbilt-Ingram Cancer Center
NCT06593106
Recruiting
Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial
Stage I Lung Cancer
NCT06828588 EARLY_Phase 1
Recruiting
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Locally Advanced Cancer
NCT05501665 Phase 1, Phase 2
Recruiting
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
Lung Non-Small Cell Carcinoma
NCT03932786
Recruiting
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Retinoblastoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology